Literature DB >> 27682182

Beneficial Effects of Exogenous Melatonin in Acute Staphylococcus aureus and Escherichia coli Infection-Induced Inflammation and Associated Behavioral Response in Mice After Exposure to Short Photoperiod.

Biswadev Bishayi1, Rana Adhikary2, Ajeya Nandi2, Sahin Sultana2.   

Abstract

The administration of melatonin during acute bacterial infection was evaluated in this study. Mice pre-exposed to normal photoperiodic (NP), short photoperiodic (SP), and long photoperiodic (LP) day lengths were infected separately with live Staphylococcus aureus (5 × 106 cells/ml) or Escherichia coli (2.5 × 107 colony-forming units/ml) and treated with melatonin (10 mg/kg body weight). Behavioral studies were performed before bacterial infection and after melatonin administration. In mice pre-exposed to SP, exogenous melatonin administration resulted in better clearance of bacteria from blood and behavioral improvement. Reduced glutathione content and superoxide dismutase activities were increased, with concomitant decrease in lipid peroxidation content and catalase activities in the liver, brain, and spleen after exogenous melatonin administration. The overproduction of tumor necrosis factor-α, interferon-γ, and interleukin-6 during acute bacterial infection in mice exposed to different photoperiods was probably regulated by the administration of exogenous melatonin, by reducing neutrophil recruitment to spleen, expression of inducible nitric oxide synthase and cyclooxygenase-2 in hypothalamus, and C-reactive protein in the serum, and was also associated with improved behavioral response. Photoperiodic variations in inflammatory and oxidative stress markers might be correlated to serum melatonin and corticosterone levels. This study suggests that the administration of melatonin during SP exposure is protective in infection-induced inflammation than NP and LP exposure.

Entities:  

Keywords:  antioxidants; bacterial infection; cytokines; inflammation; melatonin; photoperiod

Mesh:

Substances:

Year:  2016        PMID: 27682182     DOI: 10.1007/s10753-016-0445-9

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  86 in total

Review 1.  Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence.

Authors:  Germaine Escames; Darío Acuña-Castroviejo; Luis Carlos López; Dun-xian Tan; Maria Dolores Maldonado; Marina Sánchez-Hidalgo; Josefa León; Russel J Reiter
Journal:  J Pharm Pharmacol       Date:  2006-09       Impact factor: 3.765

2.  Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects.

Authors:  Antonio Carrillo-Vico; Patricia J Lardone; Latifa Naji; José M Fernández-Santos; Inés Martín-Lacave; Juan M Guerrero; Juan R Calvo
Journal:  J Pineal Res       Date:  2005-11       Impact factor: 13.007

Review 3.  Melatonin in bacterial and viral infections with focus on sepsis: a review.

Authors:  Venkataramanujam Srinivasan; Mahaneem Mohamed; Hisanori Kato
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2012-01

4.  The influence of melatonin on growth of E. coli O157:H7 in pure culture and exogenous melatonin on faecal shedding of E. coli O157:H7 in experimentally infected wethers.

Authors:  C L Schultz; T S Edrington; T R Callaway; S B Schroeder; D M Hallford; K J Genovese; R C Anderson; D J Nisbet
Journal:  Lett Appl Microbiol       Date:  2006-07       Impact factor: 2.858

5.  Circadian perinatal photoperiod has enduring effects on retinal dopamine and visual function.

Authors:  Chad R Jackson; Megan Capozzi; Heng Dai; Douglas G McMahon
Journal:  J Neurosci       Date:  2014-03-26       Impact factor: 6.167

6.  Melatonin as an antibiotic: new insights into the actions of this ubiquitous molecule.

Authors:  Omer Faruk Tekbas; Recai Ogur; Ahmet Korkmaz; Abdullah Kilic; Russel J Reiter
Journal:  J Pineal Res       Date:  2008-03       Impact factor: 13.007

7.  Repeated systemic Escherichia coli infection enhances anti-oxidant response in hypercholesterolemic mice inducing cardiovascular inflammation.

Authors:  Kallol Dutta; Debolina Nandi; Biswadev Bishayi
Journal:  Inflammation       Date:  2009-04       Impact factor: 4.092

8.  Melatonin stimulates antioxidant enzymes and reduces oxidative stress in experimental traumatic brain injury: the Nrf2-ARE signaling pathway as a potential mechanism.

Authors:  Ke Ding; Handong Wang; Jianguo Xu; Tao Li; Li Zhang; Yu Ding; Lin Zhu; Jin He; Mengliang Zhou
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

9.  The Protective Effects of Exogenous Melatonin on Nicotine-induced Changes in Mouse Ovarian Follicles.

Authors:  Fahimeh Mohammadghasemi; Sina Khajeh Jahromi; Hadi Hajizadeh; Mohammad Amin Homafar; Nazanin Saadat
Journal:  J Reprod Infertil       Date:  2012-07

Review 10.  Melatonin: its possible role in the management of viral infections--a brief review.

Authors:  Michela Silvestri; Giovanni A Rossi
Journal:  Ital J Pediatr       Date:  2013-10-03       Impact factor: 2.638

View more
  3 in total

1.  Neutralization of MMP-2 and TNFR1 Regulates the Severity of S. aureus-Induced Septic Arthritis by Differential Alteration of Local and Systemic Proinflammatory Cytokines in Mice.

Authors:  Sahin Sultana; Rana Adhikary; Biswadev Bishayi
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

Review 2.  Insight of Melatonin: The Potential of Melatonin to Treat Bacteria-Induced Mastitis.

Authors:  Hongyang Li; Peng Sun
Journal:  Antioxidants (Basel)       Date:  2022-06-02

3.  Melatonin attenuates detrimental effects of diabetes on the niche of mouse spermatogonial stem cells by maintaining Leydig cells.

Authors:  Zhaoyu Du; Shuanshuan Xu; Shuxian Hu; Hong Yang; Zhe Zhou; Kuldip Sidhu; Yiliang Miao; Zhonghua Liu; Wei Shen; Russel J Reiter; Jinlian Hua; Sha Peng
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.